Can an immunotherapy drug boost chemotherapy's power against a tough breast cancer?
NCT ID NCT06419621
First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time
Summary
This phase 3 trial is testing whether adding an experimental immunotherapy drug called PM8002 to standard chemotherapy (nab-paclitaxel) can help people with advanced triple-negative breast cancer live longer without their disease worsening. The study enrolls women aged 18 to 70 whose cancer cannot be removed by surgery or has spread. Participants receive either PM8002 plus chemotherapy or a placebo plus chemotherapy, and researchers track how long the cancer stays under control and overall survival.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- an experimental immunotherapy drug called PM8002 combined with a chemotherapy drug nab-paclitaxel
- What this could lead to
- If successful, this combination could offer a new first-line treatment option for people with advanced triple-negative breast cancer, potentially slowing disease progression.
- What could go wrong
- This is an early-phase trial, so the benefits are not yet proven. Immunotherapy can cause immune-related side effects, and the combination may not improve outcomes over standard chemotherapy alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE-NEGATIVE BREAST CANCER (TNBC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Hospital of Hebei University
Baoding, Hebei, China
-
Affiliated Zhongshan Hospital of Dalian University
Dalian, Liaoning, China
-
Affiliated hospital of Jining Medical University
Jining, Shandong, China
-
Affillated Cancer Hospital and Institute of Guangzhou Medical University
Guangzhou, Guangdong, China
-
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
-
Chongqing University Cancer Hospital
Chongqing, Chongqing Municipality, China
-
Fifth Medical Center of Chinese PLA General Hospital
Beijing, Beijing Municipality, China
-
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
-
Fujian Provincial Cancer Hospital
Fuzhou, Fujian, China
-
Guangxi Medical University Cancer Hospital
Nanning, Guangxi, China
-
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China
-
Henan Cancer Hospital
Zhengzhou, Henan, China
-
Hubei Cancer Hospital
Wuhan, Hubei, China
-
Hunan Cancer Hospital
Changsha, Hunan, China
-
Jiangsu Province Hospital
Nanjing, Jiangsu, China
-
Jiangxi Cancer Hospital
Nanchang, Jiangxi, China
-
Jilin Cancer Hospital
Changchun, Jilin, China
-
Lanzhou University First Hospital
Lanzhou, Gansu, China
-
Liaoning Cancer Hospital
Shenyang, Liaoning, China
-
Linyi Cancer Hospital
Linyi, Shandong, China
-
Mianyang Central Hospital
Mianyang, Sichuan, China
-
Nanchong Central Hospital of Sichuan Province
Nanchong, Sichuan, China
-
Nanyang Central Hospital
Nanyang, Henan, China
-
Northern Jiangsu People's Hospital
Yangzhou, Jiangsu, China
-
Obstetrics and Gynecology Hospital of Fudan University
Shanghai, Shanghai Municipality, China
-
Ruijin hospital of Shanghai Jiao Tong university School of Medicine
Shanghai, Shanghai Municipality, China
-
Runcheng City Center Hospital
Yuncheng, Shanxi, China
-
Shandong Cancer Hospital
Jinan, Shandong, China
-
Shanxi cancer hospital
Taiyuan, Shanxi, China
-
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China
-
Sichuan Cancer Hospital
Chengdu, Sichuan, China
-
Sichuan Provincial People's Hospital
Chengdu, Sichuan, China
-
Suining Central Hospital
Suining, Sichuan, China
-
Sun Yat-sen Memorial Hospital Affiliated to Sun Yat-sen University
Guangzhou, Guangdong, China
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China
-
Taizhou Hospital of Zhejiang Province
Taizhou, Zhejiang, China
-
The Affiliated Anyang Tumor Hospital of Henan University of Science and Technology
Anyang, Henan, China
-
The Affiliated Hospital of Nantong University
Nantong, Jiangsu, China
-
The Affiliated Hospital of Qingdao University
Qingdao, Shandong, China
-
The Central Hospital of Yongzhou
Yongzhou, Hunan, China
-
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
-
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
-
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China
-
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, China
-
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China
-
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China
-
The First Affiliated Hospital of Xinxiang Medical University
Xinxiang, Henan, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
-
The First Hospital of China Medical University
Shenyang, Liaoning, China
-
The First Hospital of Jilin University
Changchun, Jilin, China
-
The First People's Hospital of Changde City
Changde, Hunan, China
-
The First People's Hospital of Foshan
Foshan, Guangdong, China
-
The First People's Hospital of Neijiang
Neijiang, Sichuan, China
-
The Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
-
The Second Affiliated Hospital Zhejiang University School Of Medicine
Hangzhou, Zhejiang, China
-
The Second Affiliated Hospital of Suzhou University
Suzhou, Jiangsu, China
-
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China
-
The Second Hospital Of Dalian Medical University
Dalian, Liaoning, China
-
The Second People's Hospital Of Neijiang
Neijiang, Sichuan, China
-
The Southwest Hospital of Army Medical University
Chongqing, Chongqing Municipality, China
-
The first affiliated hospital of bengbu medical University
Bengbu, Anhui, China
-
Tian Jin Medicial University Cancer Institute&Hospital
Tianjin, Tianjin Municipality, China
-
Union Hospital Tongji Medical College of Hust
Wuhan, Hubei, China
-
Weifang People's Hospital
Weifang, Shandong, China
-
Xiangyang Cancer Hospital
Xiangyang, Hunan, China
-
Xuzhou Central Hospital
Xuzhou, Jiangsu, China
-
Yuebei People's Hospital
Shaoguan, Guangdong, China
-
Yunnan Cancer Hospital (The Third Affiliated Hospital of Kunming Medical University)
Kunming, Yunnan, China
-
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
-
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Four-Drug combo erase Triple-Negative breast cancer before surgery?
- Can a Custom-Made vaccine outsmart Triple-Negative breast cancer?
- Can a drug combo outsmart a tough breast cancer subtype?
- Can a new drug combo outsmart triple-negative breast cancer?
- Can your own immune cells fight advanced cancer?
- Can a biomarker spare breast cancer patients from harsh chemo?